# Bloxiverz

NDC: 51754-1200
Generic name: Neostigmine Methylsulfate
Labeler / Manufacturer: Exela Pharma Sciences, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20231106

FDA application: NDA204078

## Active ingredients

- NEOSTIGMINE METHYLSULFATE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51754-1200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51754-1200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2f55643-2b0d-4ef9-a9d8-b7138b314372